ASX - By Stock
|
DXB |
Re:
Ann: Change of Director's Interest Notice - HA & SP
|
|
ma420
|
8 |
4.2K |
3 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
8
|
4.2K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ma420
|
21 |
6.9K |
15 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
21
|
6.9K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
ma420
|
132 |
34K |
21 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
132
|
34K
|
21
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
ma420
|
132 |
34K |
2 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
132
|
34K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - General discussion
|
|
ma420
|
483 |
184K |
2 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
483
|
184K
|
2
|
|
ASX - By Stock
|
NUZ |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
ma420
|
68 |
16K |
9 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
68
|
16K
|
9
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Phase 2 blood cancer trial fully recruited
|
|
ma420
|
31 |
10K |
10 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
31
|
10K
|
10
|
|
ASX - By Stock
|
CVB |
Re:
Ann: Trading Halt
|
|
ma420
|
4 |
833 |
1 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
4
|
833
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - General discussion
|
|
ma420
|
483 |
184K |
1 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
483
|
184K
|
1
|
|
ASX - By Stock
|
CVB |
Re:
Ann: Trading Halt
|
|
ma420
|
4 |
833 |
0 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
4
|
833
|
0
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Further Significant Improvement in Rett Syndrome Patients
|
|
ma420
|
15 |
4.3K |
8 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
15
|
4.3K
|
8
|
|
ASX - By Stock
|
NUZ |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
ma420
|
68 |
16K |
15 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
68
|
16K
|
15
|
|
ASX - By Stock
|
COV |
Re:
Ann: CLEO Selects U.S. Clinical Trial Sites
|
|
ma420
|
8 |
4.6K |
8 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
8
|
4.6K
|
8
|
|
ASX - By Stock
|
NUZ |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
ma420
|
68 |
16K |
10 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
68
|
16K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
ma420
|
132 |
34K |
6 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
132
|
34K
|
6
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Placement
|
|
ma420
|
18 |
4.1K |
5 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
18
|
4.1K
|
5
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Placement
|
|
ma420
|
18 |
4.1K |
3 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
18
|
4.1K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
ma420
|
132 |
34K |
2 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
132
|
34K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
ma420
|
81 |
24K |
31 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
81
|
24K
|
31
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix presentation at Bio Connections Australia
|
|
ma420
|
29 |
12K |
9 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
29
|
12K
|
9
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Trading Halt
|
|
ma420
|
34 |
8.4K |
2 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
34
|
8.4K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Trading Halt
|
|
ma420
|
34 |
8.4K |
4 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
34
|
8.4K
|
4
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Trading Halt
|
|
ma420
|
34 |
8.4K |
4 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
34
|
8.4K
|
4
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
1.2K |
455K |
9 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
1.2K
|
455K
|
9
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Trading Halt
|
|
ma420
|
34 |
8.4K |
5 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
34
|
8.4K
|
5
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Trading Halt
|
|
ma420
|
34 |
8.4K |
3 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
34
|
8.4K
|
3
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Trading Halt
|
|
ma420
|
34 |
8.4K |
7 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
34
|
8.4K
|
7
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Trading Halt
|
|
ma420
|
34 |
8.4K |
2 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
34
|
8.4K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Trading Halt
|
|
ma420
|
34 |
8.4K |
3 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
34
|
8.4K
|
3
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Trading Halt
|
|
ma420
|
34 |
8.4K |
13 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
34
|
8.4K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
ma420
|
924 |
288K |
65 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
924
|
288K
|
65
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
ma420
|
924 |
288K |
10 |
28/07/24 |
28/07/24 |
ASX - By Stock
|
924
|
288K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
ma420
|
924 |
288K |
5 |
28/07/24 |
28/07/24 |
ASX - By Stock
|
924
|
288K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Race Oncology - Cashflow Forecast to December 2024
|
|
ma420
|
27 |
9.7K |
25 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
27
|
9.7K
|
25
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
630 |
267K |
5 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
630
|
267K
|
5
|
|
ASX - By Stock
|
COV |
Re:
Cleo Media Thread
|
|
ma420
|
9 |
5.0K |
2 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
9
|
5.0K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
630 |
267K |
10 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
630
|
267K
|
10
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
630 |
267K |
7 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
630
|
267K
|
7
|
|
ASX - By Stock
|
COV |
Re:
Cleo Media Thread
|
|
ma420
|
9 |
5.0K |
2 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
9
|
5.0K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
ma420
|
132 |
34K |
13 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
132
|
34K
|
13
|
|
ASX - By Stock
|
SNT |
Re:
Biotech Showcase
|
|
ma420
|
1 |
651 |
1 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
1
|
651
|
1
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ma420
|
10 |
2.4K |
3 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
10
|
2.4K
|
3
|
|
ASX - By Stock
|
COV |
Re:
Ann: Quarterly activities and cashflow report
|
|
ma420
|
2 |
1.2K |
3 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
2
|
1.2K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
630 |
267K |
9 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
630
|
267K
|
9
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
630 |
267K |
6 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
630
|
267K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report and Appendix 4C
|
|
ma420
|
34 |
11K |
35 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
34
|
11K
|
35
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: PharmAust Completes Share Purchase Plan
|
|
ma420
|
107 |
29K |
21 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
107
|
29K
|
21
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
ma420
|
3.0K |
1.0M |
7 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
3.0K
|
1.0M
|
7
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
630 |
267K |
3 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
630
|
267K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
ma420
|
3.0K |
1.0M |
2 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
3.0K
|
1.0M
|
2
|
|